Clinical Trial Update: A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CDX-011 (CR011-vcMMAE) for advanced GPNMB-expressing breast cancer has completed enrollment. The sponsor of the study is Celldex Therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDX-011 (CR011-vcMMAE)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED